Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

Clinical trial NCT01729455 · COMPLETED

Trial details

NCT number: NCT01729455
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus

Start date: 2013-02-21
Primary completion: 2025-02-28
Enrollment: 3138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.